Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 13Recruiting 4Unknown 3Terminated 3Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 62Breast 28Sarcoma 15Other hematologic neoplasm 15Gynecologic 11Plasma cell 6Genitourinary 6Gastrointestinal 6CNS 5Thoracic 2Other solid neoplasm 2Tumor-Agnostic 1

Conditions

Retinoblastoma 1HER2-negative Breast Cancer 1

Interventions

pembrolizumab 27Pemetrexed 10Nivolumab 10Cyclophosphamide 10Carboplatin 10atezolizumab 8Specimen Handling 8Cisplatin 8Ipilimumab 6Biopsy 6fludarabine 5Injections 5tislelizumab 4spartalizumab 4Vincristine 4Radiotherapy 4Proton Therapy 4Platinum 4Paclitaxel 4Drug Therapy 4Docetaxel 4Bevacizumab 41,2-diaminocyclohexaneplatinum II citrate 4sintilimab 3durvalumab 3Trastuzumab 3Etoposide 3Cetuximab 3zimberelimab 2trametinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Doxorubicin × Other solid neoplasm × Clear all
NCT05275777 2025-07-25

A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer

National University Hospital, Singapore

Phase 1/2 Active not recruiting
66 enrolled
BreastOther solid neoplasm

HER2-negative Breast Cancer

NCT01783535 2024-04-16

Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
174 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡